Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $772.89 billion, total revenue of $166.27 billion and a weighted average PE ratio of 51.92.
Market Cap
772.89B
Revenue
166.27B
Profits
14.89B
PE Ratio
51.92
Profit Margin
8.95%
Dividend Yield
0.19%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 215.18B | -0.18% | 1,167,866 | 43.74B |
| 2 | DHR | Danaher Corporation | 156.94B | -0.10% | 2,987,270 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.05B | -1.11% | 767,780 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 41.12B | 0.46% | 1,443,693 | 6.79B |
| 5 | IQV | IQVIA Holdings Inc. | 36.97B | -0.17% | 980,661 | 15.90B |
| 6 | NTRA | Natera, Inc. | 31.13B | 3.30% | 3,445,057 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.59B | -0.36% | 96,774 | 3.94B |
| 8 | WAT | Waters Corporation | 22.54B | 0.63% | 361,964 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.68B | 0.35% | 494,938 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 20.87B | 0.89% | 1,104,444 | 10.85B |
| 11 | EXAS | Exact Sciences Corporation | 19.07B | 16.81% | 67,812,161 | 3.08B |
| 12 | ILMN | Illumina, Inc. | 18.22B | -0.72% | 2,408,965 | 4.29B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.51B | -1.02% | 137,236 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 12.64B | 0.75% | 5,522,772 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 12.07B | -0.43% | 1,413,791 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 10.66B | 1.92% | 1,204,008 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 9.90B | 2.79% | 1,456,784 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 7.98B | 0.27% | 579,385 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 6.11B | -1.28% | 864,161 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.49B | 0.06% | 2,225,483 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.28B | -1.76% | 160,350 | 209.03M |
| 22 | WGS | GeneDx Holdings Corp. | 3.88B | 0.34% | 500,270 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.34B | -2.64% | 1,574,859 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.23B | 2.30% | 990,410 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.59B | 2.44% | 2,109,936 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.37B | 3.11% | 2,231,761 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.18B | -2.87% | 2,277,376 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.04B | 3.09% | 745,770 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 998.01M | -0.76% | 3,796,864 | 642.07M |
| 30 | FLGT | Fulgent Genetics, Inc. | 889.66M | -0.76% | 354,328 | 315.55M |
| 31 | CDNA | CareDx, Inc | 810.58M | -1.38% | 682,993 | 358.00M |
| 32 | PSNL | Personalis, Inc. | 735.30M | 0.49% | 1,637,615 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 643.17M | 7.14% | 1,376,832 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 216.75M | 1.34% | 167,867 | 77.08M |
| 35 | XGN | Exagen Inc. | 176.09M | -1.77% | 283,155 | 63.60M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 173.99M | 1.17% | 54,691 | 4.40M |
| 37 | BNR | Burning Rock Biotech Limited | 167.24M | -3.10% | 72,706 | 75.75M |
| 38 | MDXH | MDxHealth SA | 160.87M | -0.31% | 122,229 | 103.07M |
| 39 | FONR | FONAR Corporation | 94.21M | 0.14% | 15,209 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 51.79M | -5.65% | 87,516 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 41.49M | -2.40% | 29,625 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 29.39M | 3.51% | 811,167 | 505.30M |
| 43 | BNBX | BNB Plus Corp. | 10.89M | -7.06% | 31,444 | 3.74M |
| 44 | ADVB | Advanced Biomed Inc. | 8.17M | -8.66% | 243,529 | - |
| 45 | PRPH | ProPhase Labs, Inc. | 7.97M | -17.86% | 4,065,374 | 5.59M |
| 46 | CHEK | Check-Cap Ltd. | 7.90M | -6.90% | 52,051 | - |
| 47 | NDRA | ENDRA Life Sciences Inc. | 6.58M | -15.19% | 115,954 | - |
| 48 | BIAF | bioAffinity Technologies, Inc. | 6.21M | -6.12% | 68,143 | 6.78M |
| 49 | MYNZ | Mainz Biomed N.V. | 5.74M | -5.36% | 442,774 | 659.94K |
| 50 | XWEL | XWELL, Inc. | 4.36M | -10.83% | 75,197 | 29.52M |
| 51 | ISPC | iSpecimen Inc. | 4.11M | -16.96% | 361,301 | 3.35M |